Acute Kidney Injury News

Researchers at Brigham and Women’s Hospital developed a tool that predicts risks for moderate to severe kidney injury after treatment with the chemotherapy drug cisplatin.

Age may work as a protective factor against incident kidney failure with replacement therapy but not against death, according to results from a national cohort study of U.S. veterans.

Neonatal recurrent AKI may be associated with longer hospital stays compared with single AKI episodes, according to researchers.

Measuring baseline and post-acute kidney function is key in evaluating the risk of adverse outcomes in patients requiring dialysis, according to a nationwide cohort study.

Adults who survive COVID-AKI hospitalization may experience fewer major adverse kidney events and lower mortality than patients with AKI tied to with other illnesses, according to published data.

Major adverse kidney events occurred in a large portion of youths 90 days after undergoing continuous kidney replacement therapy, according to a published cohort study.

Obesity may be linked to a higher risk of developing early sepsis-associated AKI in adults admitted to the ICU, according to a recently published study.

Maladaptive proximal tubule cells may play a key role in the long-term effect of AKI, according to data from the Kidney Precision Medicine Project.

Use of nonselective beta-blockers was associated with stage 2 acute kidney injury and all-cause mortality among patients with decompensated cirrhosis waitlisted for liver transplantation, data showed.

Healio has compiled a list of its most-read news items regarding AKI in 2023.